No takes yet. Share an insight, caveat, or question.
Assessing secondary malignancies in organs from breast cancer radiotherapy highlights risks of treatment placement.
Hashemi et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: